ACU vs SMID

For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.

8% revenue growth year-over-year, versus 1. 1% for Acme United Corporation (ACU). Acme United Corporation (ACU) offers the better valuation at 17. 0x trailing P/E (17. 3x forward), making it the more compelling value choice. Analysts rate Acme United Corporation (ACU) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Acme United Corporation (ACU) is the cheapest at 17.

0x versus Smith-Midland Corporation at 23. 9x.

Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +170.

7%, compared to +1. 7% for Acme United Corporation (ACU). Over 10 years, the gap is even starker: SMID returned +1418% versus ACU's +170. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Acme United Corporation (ACU) is the lower-risk stock at 0.

80β versus Smith-Midland Corporation's 1. 58β — meaning SMID is approximately 98% more volatile than ACU relative to the S&P 500. On balance sheet safety, Smith-Midland Corporation (SMID) carries a lower debt/equity ratio of 12% versus 24% for Acme United Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.

8% versus 1. 1% for Acme United Corporation (ACU). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to 1. 6% for Acme United Corporation. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Smith-Midland Corporation (SMID) is the more profitable company, earning 9.

8% net margin versus 5. 2% for Acme United Corporation — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMID leads at 12. 6% versus 7. 5% for ACU. At the gross margin level — before operating expenses — ACU leads at 39. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, ACU (1.

4% yield) pays a dividend. SMID does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Acme United Corporation (ACU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

80), 1. 4% yield, +170. 9% 10Y return). Smith-Midland Corporation (SMID) carries a higher beta of 1. 58 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACU: +170. 9%, SMID: +1418%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ACU (Consumer Defensive) and SMID (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ACU is a small-cap deep-value stock; SMID is a small-cap high-growth stock. ACU pays a dividend while SMID does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.